These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9192181)

  • 1. Mechanism and regulation of bone resorption by osteoclasts.
    Katunuma N
    Curr Top Cell Regul; 1997; 35():179-92. PubMed ID: 9192181
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemical localization of cathepsins B, D and L in the rat osteoclast.
    Goto T; Tsukuba T; Kiyoshima T; Nishimura Y; Kato K; Yamamoto K; Tanaka T
    Histochemistry; 1993 May; 99(5):411-4. PubMed ID: 8335484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B and L activities in isolated osteoclasts.
    Rifkin BR; Vernillo AT; Kleckner AP; Auszmann JM; Rosenberg LR; Zimmerman M
    Biochem Biophys Res Commun; 1991 Aug; 179(1):63-9. PubMed ID: 1883385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of cathepsin L on bone resorption.
    Kakegawa H; Nikawa T; Tagami K; Kamioka H; Sumitani K; Kawata T; Drobnic-Kosorok M; Lenarcic B; Turk V; Katunuma N
    FEBS Lett; 1993 Apr; 321(2-3):247-50. PubMed ID: 8477857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanisms and regulation of procathepsin L secretion from osteoclasts in bone resorption.
    Tagami K; Kakegawa H; Kamioka H; Sumitani K; Kawata T; Lenarcic B; Turk V; Katunuma N
    FEBS Lett; 1994 Apr; 342(3):308-12. PubMed ID: 8150090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of bone resorption by tetracyclines.
    Rifkin BR; Vernillo AT; Golub LM; Ramamurthy NS
    Ann N Y Acad Sci; 1994 Sep; 732():165-80. PubMed ID: 7978789
    [No Abstract]   [Full Text] [Related]  

  • 7. Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitro.
    James IE; Marquis RW; Blake SM; Hwang SM; Gress CJ; Ru Y; Zembryki D; Yamashita DS; McQueney MS; Tomaszek TA; Oh HJ; Gowen M; Veber DF; Lark MW
    J Biol Chem; 2001 Apr; 276(15):11507-11. PubMed ID: 11148212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory mechanisms of H(+)-ATPase inhibitor bafilomycin A1 and carbonic anhydrase II inhibitor acetazolamide on experimental bone resorption.
    Ohba Y; Ohba T; Sumitani K; Tagami-Kondoh K; Hiura K; Miki Y; Kakegawa H; Takano-Yamamoto T; Katunuma N
    FEBS Lett; 1996 Jun; 387(2-3):175-8. PubMed ID: 8674544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles of cathepsin K and cathepsin L in osteoclastic bone resorption.
    Furuyama N; Fujisawa Y
    Endocr Res; 2000 May; 26(2):189-204. PubMed ID: 10921447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages.
    Punturieri A; Filippov S; Allen E; Caras I; Murray R; Reddy V; Weiss SJ
    J Exp Med; 2000 Sep; 192(6):789-99. PubMed ID: 10993910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an inhibitor of cathepsin L on bone resorption in thyroparathyroidectomized and ovariectomized rats.
    Millest AJ; Breen SA; Loveday BE; Clarkson PN; Simpson CA; Waterton JC; Johnstone D
    Bone; 1997 May; 20(5):465-71. PubMed ID: 9145244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the functional share of lysosomal cathepsins by the development of specific inhibitors.
    Katunuma N; Matsui A; Kakegawa T; Murata E; Asao T; Ohba Y
    Adv Enzyme Regul; 1999; 39():247-60. PubMed ID: 10470376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
    Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
    J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of cathepsins B, H, and L in perikaryal condensation of CA1 pyramidal neurons undergoing apoptosis after brief ischemia.
    Nitatori T; Sato N; Kominami E; Uchiyama Y
    Adv Exp Med Biol; 1996; 389():177-85. PubMed ID: 8861009
    [No Abstract]   [Full Text] [Related]  

  • 15. A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat.
    Lark MW; Stroup GB; James IE; Dodds RA; Hwang SM; Blake SM; Lechowska BA; Hoffman SJ; Smith BR; Kapadia R; Liang X; Erhard K; Ru Y; Dong X; Marquis RW; Veber D; Gowen M
    Bone; 2002 May; 30(5):746-53. PubMed ID: 11996914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin K, osteoclastic resorption, and osteoporosis therapy.
    Zaidi M; Troen B; Moonga BS; Abe E
    J Bone Miner Res; 2001 Oct; 16(10):1747-9. PubMed ID: 11585336
    [No Abstract]   [Full Text] [Related]  

  • 17. Cathepsins B, H, L and cysteine proteinase inhibitors in renal cell carcinoma: no evidence for dysregulated proteolytic balance.
    Jung K; Friedrich B; Türk I; Roigas J; Lein M; Schnorr D; Loening SA
    J Cancer Res Clin Oncol; 1998 Jan; 124(1):60-1. PubMed ID: 9498837
    [No Abstract]   [Full Text] [Related]  

  • 18. WF14861, a new cathepsins B and L inhibitor produced by Colletotrichum sp. II. Biological properties.
    Otsuka T; Muramatsu Y; Niikura K; Okamoto M; Hino M; Hashimoto S
    J Antibiot (Tokyo); 1999 Jun; 52(6):542-7. PubMed ID: 10470678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.
    Falgueyret JP; Oballa RM; Okamoto O; Wesolowski G; Aubin Y; Rydzewski RM; Prasit P; Riendeau D; Rodan SB; Percival MD
    J Med Chem; 2001 Jan; 44(1):94-104. PubMed ID: 11141092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel physiological functions of cathepsins B and L on antigen processing and osteoclastic bone resorption.
    Katunuma N; Matsunaga Y; Matsui A; Kakegawa H; Endo K; Inubushi T; Saibara T; Ohba Y; Kakiuchi T
    Adv Enzyme Regul; 1998; 38():235-51. PubMed ID: 9762356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.